Zhejiang NHU Company Ltd.
002001
Rangering i aksjer
#1848
Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang,... Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang, China, specializes in the nationwide production and distribution of a broad spectrum of chemical products. Its principal operations are divided into four main categories: 1. Nutritional Products: The company offers a comprehensive range of supplements, including essential vitamins (E, A, C, D3, biotin), DL-Methionine, coenzyme Q10, and various carotenoids. These ingredients are critical for enhancing animal feed and fortifying food, beverages, and health-related products. 2. Flavors and Fragrances: This segment supplies a variety of aroma chemicals, such as derivatives from the linalool and citral series, cis-3-hexenol, methyl dihydrojasmonate, raspberry ketone, and ligustral, which are widely utilized in personal care items, cosmetic formulations, and food flavorings. 3. New Polymer Materials: Zhejiang NHU provides advanced polymer solutions like polyphenylene sulfide and polyphthalamide. These materials find essential applications across industries including electronics, automotive manufacturing, and environmental protection. 4. Active Pharmaceutical Ingredients (APIs): The company manufactures crucial pharmaceutical components, including moxifloxacin hydrochloride, vitamin A, and vitamin D3, which serve as foundational substances for the development and production of various drug preparations.
Aksjekurs
$3.74
Markedsverdi
$11.51B
Endring (1 dag)
-1.75%
Endring (1 år)
14.61%
Land
CN
Handel Zhejiang NHU Company Ltd. (002001)
Kategori
Healthcare
P/E-forhold for Zhejiang NHU Company Ltd. (002001)
P/E-forhold per October 2026 TTM: 10.94
Ifølge Zhejiang NHU Company Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 10.94. Ved slutten av 2023 hadde selskapet en P/E på 19.49.
P/E-forholdshistorikk for Zhejiang NHU Company Ltd. fra 2001 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 10.94 | -4.91% |
| 2024 | 11.50 | -41.00% |
| 2023 | 19.49 | 22.47% |
| 2022 | 15.92 | -13.21% |
| 2021 | 18.34 | -9.69% |
| 2020 | 20.31 | -11.87% |
| 2019 | 23.04 | 129.06% |
| 2018 | 10.06 | -60.69% |
| 2017 | 25.59 | 43.56% |
| 2016 | 17.83 | -62.16% |
| 2015 | 47.11 | 129.69% |
| 2014 | 20.51 | 29.02% |
| 2013 | 15.90 | -1.08% |
| 2012 | 16.07 | 30.87% |
| 2011 | 12.28 | -21.75% |
| 2010 | 15.69 | 37.02% |
| 2009 | 11.45 | 87.44% |
| 2008 | 6.11 | -95.89% |
| 2007 | 148.81 | 152.67% |
| 2006 | 58.90 | 172.52% |
| 2005 | 21.61 | 48.79% |
| 2004 | 14.52 | -4.60% |
| 2003 | 15.23 | -26.59% |
| 2002 | 20.74 | -16.86% |
| 2001 | 24.95 | 0.00% |
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 34.96 | 219.67% |
IN
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.